Similar to what we observed in whole blood of these patients, mRNA and protein levels of VDR were elevated in the saliva samples of COVID-19 patients following VitD treatment (Fig. 3A–C, 0.58 log FC increase of VDR mRNA, P < 0.0001). This evidence concerns the gene VDR and COVID-19.